ArticleRadiation oncology (London, England)2021

BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.

Adam R Wolfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.